Pfizer, Starboard
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Pfizer’s stock dips after two former execs say they won’t support Starboard
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
Starboard’s stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand for its Covid-19 medicines recedes.
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer Went From Covid Star to Activist Target as Stock Fell (1)
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to lose.
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Guggenheim caught in Starboard-Pfizer crossfire
Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Pfizer Threatened Ex-CEO Over Work With Activist, Starboard Says
Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...
What Critics of Pfizer Are Getting Wrong
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Will Pfizer transform in response to Starboard’s activism?
Hedge fund Starboard Value's latest activist campaign targeting Pfizer (NYSE:PFE) has boosted the company's shares in recent ...
STAT4d
Pharmalittle: We’re reading about alleged Pfizer threats, industry payments to peer reviewers, and more
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D’Amelio Regarding Starboard Value
Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: We have decided not to be involved in the efforts of Starboard Value ...